U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2895928959Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on DialysisCompletedNo Results AvailableAnaemia|Chronic Kidney Disease (CKD)https://ClinicalTrials.gov/show/NCT02185911
2896028960Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning CigarettesCompletedNo Results AvailableSmokingOther: Leading U.S. tobacco-burning non-menthol cigarette|Other: Leading U.S. tobacco-burning menthol cigarette|Other: Electronic cigarette #1|Other: Electronic cigarette #2|Other: Electronic cigarette #3|Other: U.S. Market-sample electronic cigaretteshttps://ClinicalTrials.gov/show/NCT02185898
2896128961Perfusion Pressure Cerebral Infarction Trial (PPCI)RecruitingNo Results AvailableEmbolic Stroke|Postoperative Cognitive DysfunctionProcedure: Increased bloodpressure during CPB.https://ClinicalTrials.gov/show/NCT02185885
2896228962CrossFit Exercise to Improve Glucose Control for Overweight and Obese AdultsCompletedNo Results AvailableHyperglycemiaOther: High-Intensity Functional Training|Other: Aerobic and Resistance Traininghttps://ClinicalTrials.gov/show/NCT02185872
2896328963Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast MastectomyRecruitingNo Results AvailableBreast CancerDrug: Lidocaine|Drug: Magnesium Sulfate|Drug: Salinehttps://ClinicalTrials.gov/show/NCT02185859
2896428964Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed ConditionCompletedNo Results AvailableHealthyDrug: DYNABAC 250 MG ENTERIC COATED TABLET|Drug: DIRITHROMYCIN 500 MG ENTERIC COATED TABLEThttps://ClinicalTrials.gov/show/NCT02185846
2896528965Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting ConditionCompletedNo Results AvailableHealthyDrug: DIRITHROMYCIN 500 MG ENTERIC COATED TABLET|Drug: DYNABAC 250 MG ENTERIC COATED TABLEThttps://ClinicalTrials.gov/show/NCT02185833
2896628966Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)RecruitingNo Results AvailableMultiple MyelomaDrug: Carfilzomib|Drug: Pomalidomide|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT02185820
2896728967Video-assisted Informed Consent for Cataract SurgeryRecruitingNo Results AvailableCataract|SurgeryProcedure: video-assisted group|Procedure: control grouphttps://ClinicalTrials.gov/show/NCT02185807
2896828968Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus InfectionActive, not recruitingNo Results AvailableHepatitis C Virus InfectionDrug: GS-9857|Drug: Placebo to match GS-9857|Drug: SOF/GS-5816https://ClinicalTrials.gov/show/NCT02185794
2896928969Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)RecruitingNo Results AvailableAcute Lymphoblastic Leukemia|Complete Hematologic Remission (CHR)|Persistent/Recurrent Minimal Residual Disease (MRD)Other: Autologous NK cells infusionshttps://ClinicalTrials.gov/show/NCT02185781
2897028970Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE IIRecruitingNo Results AvailableLiver CancerDrug: idarubicin|Device: Dc- Beads 300-500µmhttps://ClinicalTrials.gov/show/NCT02185768
2897128971Internet Monitoring vs Medication to Control Blood Sugar in Type 2 DiabetesActive, not recruitingNo Results AvailableType 2 Diabetes MellitusOther: Internet-Based Glucose Monitoring System|Drug: Normal Medication Positive Controlhttps://ClinicalTrials.gov/show/NCT02185755
2897228972Planning for SUCCESSActive, not recruitingNo Results AvailableHIVBehavioral: Strength Based Case Managementhttps://ClinicalTrials.gov/show/NCT02185742
2897328973Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy VolunteersCompletedHas ResultsDiseases, Metabolic|Insulin SensitivityDrug: Intralipid|Drug: ClinOleic|Drug: Dextrose|Other: Saline (control)https://ClinicalTrials.gov/show/NCT02185729
2897428974Transversus Abdominis Plane Block (TAP) for Laparoscopic Cholecystectomy SurgeryActive, not recruitingNo Results AvailableCholecystectomy, Laparoscopic|Pain, PostoperativeDrug: Levobupivacaine 0.25 %|Drug: Levobupivacaine 0.5%https://ClinicalTrials.gov/show/NCT02185716
2897528975Chordate System S020 Acute Migraine Clinical InvestigationTerminatedNo Results AvailableAcute MigraineDevice: Chordate System S020 in treatment mode|Device: Chordate System S020 in placebo modehttps://ClinicalTrials.gov/show/NCT02185703
2897628976A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the LungNot yet recruitingNo Results AvailableCarcinoma of the Lung.Drug: Binimetinib|Drug: Pemetrexed|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT02185690
2897728977Cognitive and Behavioral Dysexecutive Syndrome in Multiple System AtrophyRecruitingNo Results AvailableMultiple System AtrophyOther: Clinical evaluation|Other: neuropsychological battery test|Other: MRI|Other: Actigraphyhttps://ClinicalTrials.gov/show/NCT02185677
2897828978Use of Static Ultrasound Guidance for Internal Jugular Vein Cannulation in Adult Cardiac Surgical PatientsCompletedNo Results AvailableAdult Cardiac Surgical PatientsProcedure: landmark technique|Device: Static Ultrasound techniquehttps://ClinicalTrials.gov/show/NCT02185664
2895128951Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)RecruitingNo Results AvailableAdult Women|Metastatic Breast Cancer|Estrogen Receptor PositiveDrug: Cholecalciferolhttps://ClinicalTrials.gov/show/NCT02186015
2895228952Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)CompletedNo Results AvailableHealthyDrug: ACT-451840 10 mg|Drug: ACT-451840 50 mg|Drug: ACT-451840 200 mg|Drug: ACT-451840 500 mg|Drug: ACT-451840 1000 mg|Drug: ACT-451840 (Dose to be determined)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02186002
2895328953Electrical Muscle Stimulation and Bicycling Combined to Early Standard Rehabilitation in the ICURecruitingNo Results AvailableICU-acquired Muscle WeaknessOther: Early electrical stimulation and early leg bicycling added to early standard rehabilitationhttps://ClinicalTrials.gov/show/NCT02185989
2895428954Effect of Cartoons on Preoperative Anxiety in Paediatric Patients.RecruitingNo Results AvailableAnxietyOther: cartoonhttps://ClinicalTrials.gov/show/NCT02185976
2895528955Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 DiabetesRecruitingNo Results AvailableDiabetesDrug: Rosuvastatinhttps://ClinicalTrials.gov/show/NCT02185963
2895628956The Effects of Therapeutic Resources on Structure and Function of Normal and Burned SkinRecruitingNo Results AvailableBurn|Skin GraftDevice: ultrasound|Device: paraffin|Device: endermotherapyhttps://ClinicalTrials.gov/show/NCT02185950
2895728957Influence of an Acidic Beverage on the Imatinib Exposure After Major GastrectomyRecruitingNo Results AvailableGastrointestinal Stromal Tumor|Major GastrectomyDietary Supplement: colahttps://ClinicalTrials.gov/show/NCT02185937
2895828958Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee ArthroplastyCompletedNo Results AvailablePOSTOPERATIVE ANALGESIA FOR TKA PARECOXIB/CFBDrug: Parecoxib|Drug: CONTINUOUS FEMORAL BLOCK WITH ROPIVACAINE 0,2%|Drug: N/S 0.9%https://ClinicalTrials.gov/show/NCT02185924
2897928979A Pilot Study of Zavesca® in Patients With Pompe Disease and Infusion Associated ReactionRecruitingNo Results AvailablePompe Disease|Hypersensitivity ReactionDrug: Zavesca® Prescriptionhttps://ClinicalTrials.gov/show/NCT02185651
2898028980Appetite Suppression Effects of an Herbal Combination of Yerba maté, Guarana, Damiana (YGD), and 12 Other Herbal Components, Versus YGD Supplementation AloneCompletedNo Results AvailableObesityOther: Appetite suppressant properties of YGD and A20-50https://ClinicalTrials.gov/show/NCT02185638

* Görseller ve İçerik tekif hakkına sahip olabilir